Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Nausea, constipation, and sulfur burps disappear as the medication leaves your system
Youve seen the success stories and heard about its powerful appetite-suppressing effects
Douglas and Dr
PLoS ONE 8(5):e63918
Liraglutide has been approved for multiple indications since its initial launch in 2010: 2010: Victoza approved for adults with type 2 diabetes 2014: Brand name Saxenda approved for obesity in adults 2017: Victoza approved for reducing the risk of major adverse cardiovascular (CV) events, heart attack, stroke, and CV death in adults with type 2 diabetes and established CV disease 2019: Victoza approved for pediatric patients aged ten and over with type 2 diabetes 2020: Saxenda approved for obesity in adolescents aged 12-17 Population According to the CDC, approximately 38 million adults in the United States have diabetes (90-95% is type 2 diabetes)
BMI thresholds, failed diet/behavioral programs) before allowing GLP-1 drugs ( [4] )
US$ 27.38
US$ 21.63
US$ 24.62
US$ 26.67
